查詢結果分析
來源資料
相關文獻
- Primary Resistance to Gefitinib in a Patient with Lung Adenocarcinoma Presenting as a Rare Form of Umbilical Metastasis
- erbB基因與非小細胞肺癌的原發抗藥性
- Newly Developing Osteoblastic Lesions during Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Do Not Necessarily Indicate Disease Progression
- 非小細胞肺癌術前輔助性化學治療的經驗
- The Role of Radiotherapy for Advanced Non-Small Cell Lung Cancer
- Differential Display of mRNA in Human Lung Tissue and in Non-Small Cell Lung Cancer: A Preliminary Report
- 非小細胞肺癌的治療
- 晚期非小細胞肺癌之化學治療
- CA405之基因療法合併化學抗癌藥物對肺癌細胞之作用效果評估與機轉的探討(2)
- Treatment of Non-Small-Cell Lung Cancer: The Chinese Experience in a General Teaching Hospital
頁籤選單縮合
題名 | Primary Resistance to Gefitinib in a Patient with Lung Adenocarcinoma Presenting as a Rare Form of Umbilical Metastasis=肺腺癌病患經Gefitinib治療之原發抗藥性以臍部轉移為表現 |
---|---|
作者 | 陳致宇; 陳家弘; 廖偉志; 涂智彥; 夏德椿; 施純明; 徐武輝; | 書刊名 | 胸腔醫學 |
卷期 | 31:1 2016.02[民105.02] |
頁次 | 頁41-46 |
分類號 | 415.468 |
關鍵詞 | 非小細胞肺癌; 臍部轉移; 原發抗藥性; 表皮生長因子接受體酪胺酸激酶抑制劑; Non-small cell lung cancer; Umbilical metastasis; Primary resistance; Epidermal growth factor receptor-tyrosine kinase inhibitor; |
語文 | 英文(English) |